What is Global Amyotrophic Lateral Sclerosis (ALS) Market?
The Global Amyotrophic Lateral Sclerosis (ALS) Market is a comprehensive study of the global market trends and growth prospects for ALS treatments. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. The market analysis focuses on the development, production, and consumption of treatments for this disease worldwide. The market was valued at a significant amount and is expected to grow due to the increasing prevalence of the disease and the urgent need for effective treatments. The report provides an in-depth analysis of the market size, share, growth, trends, and forecast for the global ALS market. It also covers the market dynamics, including the drivers, restraints, opportunities, and challenges, as well as the competitive landscape of the global ALS market.
Riluzole, Edaravone (Radicava), Other in the Global Amyotrophic Lateral Sclerosis (ALS) Market:
Riluzole, Edaravone (Radicava), and other treatments form the backbone of the Global Amyotrophic Lateral Sclerosis (ALS) Market. Riluzole is the first drug that was approved by the FDA for the treatment of ALS. It works by decreasing the release of glutamate, a chemical messenger in the brain, which is believed to damage nerve cells. Edaravone, on the other hand, is a newer drug that was approved by the FDA in 2017. It is believed to work by relieving the effects of oxidative stress, which is thought to be a factor in the death of nerve cells in people with ALS. Other treatments in the market include physical therapy, occupational therapy, speech therapy, nutritional support, and respiratory therapy. These treatments aim to improve the quality of life of patients and slow the progression of symptoms. The market for these treatments is expected to grow due to the increasing prevalence of ALS and the urgent need for effective treatments.
Hospital, Drugs Store, Other in the Global Amyotrophic Lateral Sclerosis (ALS) Market:
The Global Amyotrophic Lateral Sclerosis (ALS) Market is widely used in various areas such as hospitals, drug stores, and others. In hospitals, these treatments are used to manage the symptoms of ALS and improve the quality of life of patients. They are administered by healthcare professionals who are trained to handle the complex needs of ALS patients. In drug stores, these treatments are available for purchase by patients for use at home. They are often prescribed by doctors and are used under the supervision of a healthcare professional. Other areas where these treatments are used include research institutions and home healthcare. The use of these treatments in these areas is expected to increase due to the growing awareness of ALS and the increasing need for effective treatments.
Global Amyotrophic Lateral Sclerosis (ALS) Market Outlook:
The future of the Global Amyotrophic Lateral Sclerosis (ALS) Market looks promising. In 2023, the market was valued at US$ 300 million. It is expected to grow at a steady pace, reaching an estimated value of US$ 379.1 million by 2030. This represents a compound annual growth rate (CAGR) of 2.6% during the forecast period from 2024 to 2030. This growth is driven by the increasing prevalence of ALS and the urgent need for effective treatments. The market is also expected to benefit from advancements in medical technology and the development of new treatments for ALS.
| Report Metric | Details |
| Report Name | Amyotrophic Lateral Sclerosis (ALS) Market |
| Accounted market size in 2023 | US$ 300 million |
| Forecasted market size in 2030 | US$ 379.1 million |
| CAGR | 2.6% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
